Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder

European Urology

Volumn 46, Issue 1, 2004, Pages 65-72

  Van Der Heijden, A G ^a   Kiemeney, L A ^a   Gofrit, O N ^b   Nativ, O ^c   Sidi, A ^d   Leib, Z ^e   Colombo, R ^f   Naspro, R ^f   Pavone, M ^g   Baniel, J ^e   Hasner, F ^h   Witjes, J A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c BNAI ZION MEDICAL CENTER   (Israel)

^d WOLFSON MEDICAL CENTER   (Israel)

^e RABIN MEDICAL CENTER   (Israel)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g UNIVERSITY OF PALERMO   (Italy)

^h Krankenhaus Munchen Harlaching VI   (Germany)

Author keywords

Bladder cancer; Intravesical chemotherapy; Microwave induced hyperthermia; Mitomycin C; Recurrence rate

Indexed keywords

BCG VACCINE; MITOMYCIN C;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER GROWTH; CANCER RISK; CANCER STAGING; CANCER SURGERY; CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSURIA; FEMALE; FOLLOW UP; HEMATURIA; HIGH RISK PATIENT; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MICROWAVE THERAPY; MULTIPLE CANCER; PAIN; PRIORITY JOURNAL; RECURRENT CANCER; SKIN ALLERGY; SUPERFICIAL CANCER; TISSUE REACTION; TRANSITIONAL CELL CARCINOMA; URETHRA STENOSIS; URINE CYTOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; DIATHERMY; EUROPE; FEMALE; HUMANS; MALE; MICROWAVES; MIDDLE AGED; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 2942538278     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2004.01.019     Document Type: Article

References (29)

1. Kiemeney L.A., Witjes J.A., Heijbroek R.P., Verbeek A.L., Debruyne F.M. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J. Urol. 150(1):1993;60-64
2. Pawinski A, Sylvester R, Kurth KH, Bouffioux C, van der Meijden A, Parmar MK, et al. A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer. J Urol 1996;156(6):1934-40, discussion.
3. Herr H.W. Transurethral resection and intravesical therapy of superficial bladder tumors. Urol. Clin. North Am. 18(3):1991;525-528
4. Melekos M.D., Moutzouris G.D. Intravesical therapy of superficial bladder cancer. Curr. Pharm. Des. 6(3):2000;345-359
5. Bohle A., Jocham D., Bock P.R. Intravesical bacillus Calmette-Guerin versus Mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. J. Urol. 169(1):2003;90-95
6. Sylvester R.J., van der Meijden A.P., Lamm D.L. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J. Urol. 168(5):2002;1964-1970
7. Colombo R., Da Pozzo L.F., Lev A., Freschi M., Gallus G., Rigatti P. Neoadjuvant combined microwave induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer. J. Urol. 155(4):1996;1227-1232
8. Colombo R., Da Pozzo L.F., Lev A., Salonia A., Rigatti P., Leib Z., et al. Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors. J. Urol. 159(3):1998;783-787
9. Colombo R., Brausi M., Da Pozzo L., Salonia A., Montorsi F., Scattoni V., et al. Thermo-chemotherapy and electromotive drug administration of Mitomycin C in superficial bladder cancer eradication. a pilot study on marker lesion. Eur. Urol. 39(1):2001;95-100
10. Colombo R., Da Pozzo L.F., Salonia A., Rigatti P., Leib Z., Baniel J., et al. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J. Clin. Oncol. 21(23):2003;4270-4276
11. Herman T.S., Teicher B.A., Jochelson M., Clark J., Svensson G., Coleman C.N. Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies. Int. J. Hyperthermia. 4(2):1988;143-158
12. Oosterlinck W., Lobel B., Jakse G., Malmstrom P.U., Stockle M., Sternberg C. EAU Recommendations 2001. "Guidelines on Bladder Cancer" Prog. Urol. 12(5):2002;1161-1163
13. Colombo R., Lev A., Da Pozzo L.F., Freschi M., Gallus G., Rigatti P. A new approach using local combined microwave hyperthermia and chemotherapy in superficial transitional bladder carcinoma treatment. J. Urol. 153(3 Pt 2):1995;959-963
14. van der Heijden A.G., Witjes J.A. Future strategies in the diagnosis, staging and treatment of bladder cancer. Curr. Opin. Urol. 13(5):2003;389-395
15. Chopin D.K., Gattegno B. Superficial bladder tumors. Eur. Urol. 42(6):2002;533-541
16. Meyer J.L. The clinical efficacy of localized hyperthermia. Cancer Res. 44(10 Suppl):1984;4745s-4751s
17. Komatsu K., Miller R.C., Hall E.J. The Oncogenic Potential of a combination of hyperthermia and chemotherapy agents. Br. J. Cancer. 57(1):1988;59-63
18. Nakajima K., Hisazumi H. Enhanced radioinduced cytotoxicity of cultured human bladder cancer cells using 43 degrees C hyperthermia or anticancer drugs. Urol. Res. 15(5):1987;255-260
19. Au J.L., Badalament R.A., Wientjes M.G., Young D.C., Warner J.A., Venema P.L., et al. Methods to improve efficacy of intravesical Mitomycin C: results of a randomized phase III trial. J. Natl. Cancer Inst. 93(8):2001;597-604
20. Kiemeney L.A., Witjes J.A., Verbeek A.L., Heijbroek R.P., Debruyne F.M. The clinical epidemiology of superficial bladder cancer. Dutch South-East Cooperative Urological Group. Br. J. Cancer. 67(4):1993;806-812
21. Colombo R., Lev A., Da Pozzo L.F., Freschi M., Gallus G., Rigatti P. A new approach using local combined microwave hyperthermia and chemotherapy in superficial transitional bladder carcinoma treatment. J. Urol. 153(3 Pt 2):1995;959-963
22. van der Heijden A.G., Witjes J.A. Intervesical chemotherapy: an update - new trends and perspectives. EAU Update Series. 1:2003;71-79
23. Smith J.A. Jr., Labasky R.F., Cockett A.T., Fracchia J.A., Montie J.E., Rowland R.G. Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (Stages Ta, T1 and TIS). The American Urological Association. J. Urol. 162(5):1999;1697-1701
24. Paroni R., Salonia A., Lev A., Da Pozzo L.F., Cighetti G., Montorsi F., et al. Effect of local hyperthermia of the bladder on Mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma. Br. J. Clin. Pharmacol. 52(3):2001;273-278
25. Shelley M.D., Kynaston H., Court J., Wilt T.J., Coles B., Burgon K., et al. A systematic review of intravesical bacillus Calmette-Guerin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer. BJU Int. 88(3):2001;209-216
26. Hurle R., Manzetti A., Losa A., Micheli E., Ranieri A., Chinaglia D., et al. Intravesical instillation of Mitomycin-C in 242 patients with superficial bladder cancer at high risk of recurrence: long-term results. Urol. Int. 61(4):1998;220-226
27. O'Donnell MA, Krohn J, DeWolf WC. Salvage intravesical therapy with Interferon-Alpha 2b plus low dose bacillus Calmette-Guerin is effective in patients with superficial bladder cancer in whom bacillus Calmette-Guerin alone previously failed. J Urol 2001;166(4):1300-4 [Discussion].
28. Colombo R., Da Pozzo L.F., Salonia A., Rigatti P., Leib Z., Baniel J., et al. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J. Clin. Oncol. 21:2003;4270-4276
29. Sylvester R.J., van der Meijden A.P., Lamm D.L. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J. Urol. 168:2002;1964-1970